InnovAge Holding Corp.
$7.95
▼
-5.11%
2026-04-21 07:32:00
www.innovage.com
NMS: INNV
Explore InnovAge Holding Corp. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$1.12 B
Current Price
$7.95
52W High / Low
$10.69 / $2.6
Stock P/E
172.72
Book Value
$1.89
Dividend Yield
—
ROCE
-4.46%
ROE
1.18%
Face Value
—
EPS
$0.05
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Care Facilities
Employees
2,440
Beta
0.5
Debt / Equity
33.02
Current Ratio
1.26
Quick Ratio
1.07
Forward P/E
24.12
Price / Sales
1.22
Enterprise Value
$1.11 B
EV / EBITDA
25.73
EV / Revenue
1.22
Rating
None
Target Price
$7
EPS Forecast (FY)
—
Pros
- Balance sheet leverage appears manageable.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Operating margin is thin.
- Net margin is relatively low.
- Valuation is rich on a P/E basis.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Universal Health Services, Inc. | $180.51 | 7.82 | $11.04 B | 0.45% | 16.23% | 21.33% | $246.32 / $152.33 | $119.15 |
| 2. | biote Corp. | $2.24 | 3.25 | $87.8 M | — | 56.77% | -32.89% | $4.75 / $1.27 | $-1.91 |
| 3. | Cross Country Healthcare, Inc. | $9.96 | — | $317.69 M | — | -1.05% | -25.57% | $14.99 / $7.43 | $10.18 |
| 4. | Acadia Healthcare Company, Inc. | $27.84 | — | $2.56 B | — | 7.76% | -40.96% | $28.48 / $11.43 | $21.55 |
| 5. | Charming Medical Limited | $29.36 | 441.53 | $497.21 M | — | 396.56% | -232.79% | $31.7 / $4.3 | $0 |
| 6. | Guardian Pharmacy Services, Inc. | $37.34 | 48.3 | $2.38 B | — | 28.85% | 26.61% | $41.36 / $19.17 | $3.25 |
| 7. | Strata Critical Medical, Inc. | $4.52 | 9.61 | $397.54 M | — | -7.31% | -8.01% | $6.02 / $2.51 | $4.18 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | |
|---|---|---|---|---|---|
| Sales | 239.71 M | 236.1 M | 221.42 M | 218.14 M | 209 M |
| Operating Profit | 13.26 M | 8.39 M | 2.97 M | -10.16 M | -4.06 M |
| Net Profit | 10.62 M | 8.02 M | -0.79 M | -11.38 M | -13.22 M |
| EPS in Rs | 0.08 | 0.06 | -0.01 | -0.08 | -0.1 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 853.7 M | 763.86 M | 688.09 M | 698.64 M |
| Operating Profit | -16.15 M | -23.18 M | -49.4 M | -4.41 M |
| Net Profit | -30.31 M | -21.34 M | -40.67 M | -6.52 M |
| EPS in Rs | -0.22 | -0.16 | -0.3 | -0.05 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 526.85 M | 547.66 M | 567.36 M | 555.6 M |
| Total Liabilities | 263.94 M | 247.85 M | 252.56 M | 201.85 M |
| Equity | 234.97 M | 269.26 M | 296.3 M | 332.36 M |
| Current Assets | 176.11 M | 173.14 M | 215.23 M | 240.96 M |
| Current Liabilities | 164.81 M | 138.6 M | 148.45 M | 105.31 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 32.87 M | -36.9 M | 20.24 M | 27.3 M |
| Investing CF | -5.55 M | -26.37 M | -69.52 M | -40.24 M |
| Financing CF | -19.08 M | -7.03 M | -7.9 M | -6.32 M |
| Free CF | 26.6 M | -44.81 M | -3.12 M | -10.94 M |
| Capex | -6.26 M | -7.91 M | -23.35 M | -38.24 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | 11.01% | -1.51% | — | — |
| Earnings Growth % | 47.54% | -523.72% | — | — |
| Profit Margin % | -2.79% | -5.91% | -0.93% | — |
| Operating Margin % | -3.03% | -7.18% | -0.63% | — |
| Gross Margin % | 17.29% | 14.72% | 19.38% | — |
| EBITDA Margin % | 0.15% | -4.92% | 1.32% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.